Rapport sur la santé dans le monde

Chapitre 1


Bibliographie

  • Le point sur l’épidémie de SIDA. Décembre 2003. Genève, Programme commun des Nations Unies sur le VIH/SIDA. Document ONUSIDA/03.39F.
  • World population prospects: the 2002 revision. New York, Nations Unies, 2003.
  • Dixon S, McDonald S, Roberts J. The impact of HIV and AIDS on Africa’s economic development. BMJ, 2002, 324:232–234.
  • Topouzis D. The socio-economic impact of HIV/AIDS on rural families with an emphasis on youth. Rome, Organisation des Nations Unies pour l’Alimentation et l’Agriculture, 1994.
  • Le Progrès des nations. New York, Fonds des Nations Unies pour l’enfance, 2000 (Document de base).
  • The impact of AIDS. New York, Nations Unies, 2003 (Division de la Population, Département des Affaires économiques et sociales de l’Organisation des Nations Unies).
  • Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F et al. Mortality associated with HIV infection in rural Rakai district, Uganda. AIDS, 2000, 14:2391–2400.
  • Glynn JR, Warndorff DK , Fine PEM, Msiska GK, Munthali MM, Ponnighaus JM. The impact of HIV on morbidity and mortality from tuberculosis in sub-Saharan Africa: a study in rural Malawi and review of the literature. Health Transition Review, 1997, 7(Suppl. 2):75–87.
  • Brahmbhatta H, Kigozi G, Wabwire-Mangen F, Serwadda D, Sewankambo N, Lutalo T et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS, 2003, 17:2539–2541.
  • VIH/SIDA: Surveillance épidémiologique. Mise à jour pour la Région Afrique de l’OMS 2002. Harare, Organisation mondiale de la Santé, Bureau régional OMS de l’Afrique, 2003.
  • Reconciling survey and surveillance-based estimates. Report of Tropical Diseases Research Centre (Ndola, Zambia)/UNAIDS/WHO Technical Consultation, Lusaka, Zambia, 17–18 February 2003. Genève, Organisation mondiale de la Santé, 2003 (http://www.who.int/hiv/strategic/mt170203/en/, consulté le 14 février 2004).
  • Buve A, Carael M, Hayes R, Robinson NJ. Variations in HIV prevalence between urban areas in sub-Saharan Africa: do we understand them? AIDS, 1995, 9(Suppl. A):S103–S109.
  • Boerma JT, Nyamukapa C, Urassa M, Gregson S. Understanding the uneven spread of HIV within Africa: a comparative study of biologic, behavioral, and contextual factors in rural populations in Tanzania and Zimbabwe. Sexually Transmitted Diseases, 2003, 30:779–787.
  • Nicoll A, Hamers F. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? BMJ, 2002, 324:1324–1327.
  • Centre européen pour la surveillance épidémiologique du SIDA. Surveillance du VIH/SIDA en Europe. Décembre 2003, N° 69. Saint-Maurice, Institut de Veille Sanitaire, 2003 (http://www.eurohiv.org/reports/report_69/pdf/draft_rep69.pdf, consulté le 3 février 2004).
  • Walker N, Schwartlander B, Bryce J. Meeting international goals in child survival and HIV/AIDS. Lancet, 2002, 360:284–289.
  • Newell M-L, Brahmbhatt H, Ghys P. Child mortality and HIV infection in Africa: a review. The impact of the AIDS epidemic on child mortality. AIDS (à venir).
  • Blacker J. The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS (à venir).
  • Porter K, Zaba B. The empirical evidence for the impact of HIV on adult mortality in the developing world: data from serological studies. AIDS (à venir).
  • Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS, 2002, 16:597–603.
  • Division de la Population de l’Organisation des Nations Unies. World population prospects: the 2002 revision population database (http://esa.un.org/unpp, consulté le 18 février 2004).
  • Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodefiency virus type I-related opportunistic infections in sub-Saharan Africa. Clinical Infectious Diseases, 2003, 36:652–662.
  • Corbett EL, Steketee RW, ter Kuile FO, Latif A, Kamali A, Hayes RJ. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet, 2002, 359:2177–2187.
  • Corbett EL, Watt C, Walker N, Maher D, Williams BG, Raviglione MC et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine, 2003, 163:1009–1021.
  • Global tuberculosis control: surveillance, planning, financing. Genève, Organisation mondiale de la Santé, 2004 (WHO/HTM/TB/2004.331, sous presse).
  • Barnett T, Whiteside A. AIDS in the 21st century: disease and globalization. Londres, Macmillan Palgrave, 2002.
  • Bronfman MN, Leyva R, Negroni MJ, Rueda CM. Mobile populations and HIV/AIDS in Central America and Mexico: research for action. AIDS, 2002, 16(Suppl. 3):S42–S49.
  • Mutangadura G, Mukurazita D, Jackson H. La riposte des ménages et des communautés à l’épidémie de VIH/SIDA dans les zones rurales de l’Afrique subsaharienne. Genève, Programme commun des Nations Unies sur le VIH/SIDA, 2000.
  • Over M. Coping with the impact of AIDS. Finance and Development, 1998, March:22–24.
  • Bell C, Devarajan S, Gersbach H. The long-run economic costs of AIDS: theory and application to South Africa. Washington, D. C. Banque mondiale, 2003.
  • Les orphelins et les autres enfants touchés par le VIH/SIDA. Fiche de synthèse de l’UNICEF. Paris, Fond des Nations Unies pour l’Enfance (http://www.unicef.org/aids/index_orphans.html, consulté le 4 février 2004).
  • UNICEF/AID/ONUSIDA. Children on the brink 2002. A joint report on orphan estimates and program strategies. Washington, D. C., The Synergy Project, 2002.
  • Faire face au SIDA : les priorités de l’action publique face à une épidémie mondiale. Washington, D. C., Banque mondiale, Commission européenne, ONUSIDA, 1999.
  • McPherson M, Goldsmith A. Africa: on the move? SAIS Review, 1998, 28:153–167.
  • Husain IZ, Badcock-Walters P. Economics of HIV/AIDS mitigation: responding to problems of systemic dysfunction and sectoral capacity. In: Forsythe S. The state of the art: AIDS and economics. Washington, D. C., Policy Project, 2002:84–95.
  • Rosen S, Simon J, Vincent JR, MacLeod W, Fox M, Thea DM. AIDS is your business. Harvard Business Review, 2003, 81:80–87.
  • Forsythe S. HIV/AIDS and tourism. AIDS Analysis Africa, 1999, 9:4–6.
  • Hemrich G, Topouzis D. Multi-sectoral responses to HIV/AIDS: constraints and opportunities for technical co-operation. Journal of International Development, 2000, 12:85–99.
  • Grassly NC, Desai K, Pegurri E, Sikazwe A, Malambo I, Siamatowe C et al. The economic impact of HIV/AIDS on the education sector in Zambia. AIDS, 2003, 17:1039–1044.
  • Accelerating access to HIV/AIDS care in Swaziland. A partnership between the Kingdom of Swaziland, the United Nations system, and the private sector. Mbabane (Swaziland), Ministry of Health and Social Welfare, 2000 (Descriptif du projet).
  • Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet, 2002, 360:73–77.
  • Groupe de travail mondial pour la prévention du VIH. Global mobilization for HIV prevention: a blueprint for action. Menlo Park, Californie (Etats-Unis d’Amérique), Kaiser Family Foundation, 2002 (http://www.kff.org/hivaids/200207-index.cfm, consulté le 4 février 2004).
  • Coordenação Nacional de Dst e Aids. Pesquisa entre os conscritos do Exército Brasileiro, 1996–2000: retratos do comportamento de risco do jovem brasileiro à infecção pelo HIV. Brasília, Ministério da Saúde, 2002 (en portugais).
  • Camara B, Lee R, Gatwood J, Wagner H-U, Cazal-Gamelsy R, Boisson E. The Caribbean HIV/AIDS epidemic. Epidemiological status – success stories. A summary. Port of Spain, Caribbean Epidemiology Centre, 2003 (CAREC surveillance report, 2003, Vol. 23, Suppl. 1).
  • Sumartojo E. Structural factors in HIV prevention: concepts, examples, and implication for research. AIDS, 2000, 14(Suppl. 1):S3–S10.
  • Auerbach JD, Coates TJ. HIV prevention research: accomplishments and challenges for the third decade of AIDS. American Journal of Public Health, 2000, 90:1029–1032.
  • Le préservatif masculin. Genève, Programme commun des Nations Unies sur le VIH/SIDA, août 2000 (ONUSIDA, Actualisation).
  • Ghys PD, Diallo MO, Ettiegne-Traore V, Satten GA, Anoma CK, Maurice C et al. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS, 2001, 15:1421–1431.
  • Alary M, Mukenge-Tshibaka L, Bernier F, Geraldo N, Lowndes CM, Meda H et al. Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993–1999. AIDS, 2002, 16:463–470.
  • Groupe de travail thaïlandais sur le VIH/SIDA. Projections for HIV/AIDS in Thailand: 2000–2020. Bangkok (Thaïlande), Ministry of Public Health, 2001 (Department of Communicable Disease Control).
  • Groupe de travail cambodgien sur le VIH/SIDA. Projections for HIV/AIDS in Cambodia: 2000–2010. Phnom Penh, Centre national de lutte contre le VIH/SIDA et les MST, 2002.
  • Steen R, Vuylsteke B, DeCoito T, Ralepeli S, Fehler G, Conley J et al. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sexually Transmitted Diseases, 2000, 27:1–8.
  • Mbulaiteye SM, Mahe C, Whitworth JA, Ruberantwari A, Nakiyingi JS, Ojwiya A et al. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet, 2002, 360:41–46.
  • The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 1995, 8:506–510.
  • McDonald M, Law M, Kaldor J, Hales J, Dore GJ. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy, 2003, 14:353–357.
  • Schmid GP, Buvé A, Mugyenyi P, Garnett GP, Hayes RJ, Williams BG et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet, 2004, 363:482–488.
  • The Voluntary HIV-2 Counselling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania and Trinidad: a randomised trial. Lancet, 2000, 356:103–112.

Documents connexes

Partager